Clinical Trials Browser

Phase 1/2 × epitumomab × Clear all

NCT00066547 2013-12-04

Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy

Phase 1/2 Unknown

Breast Neoplasms